Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and Safety of FTY720 for the Treatment of Acute Stroke

Trial Profile

Efficacy and Safety of FTY720 for the Treatment of Acute Stroke

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fingolimod (Primary) ; Alteplase
  • Indications Stroke
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 08 Oct 2018 Primary endpoint (the favorable shift of modified Rankin scale score (mRS) distribution at day 90) has been met.
    • 08 Oct 2018 Results published in the Annals of Neurology
    • 22 Jul 2015 Status changed from recruiting to completed according to the results published in the Circulation according to the results published in the Circulation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top